StacksVerified U.S. regulatory reference

21 CFR §333.110

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
The product consists of any of the following active ingredients within the specified concentration established for each ingredient and in the specified dosage form:
  1. (a)Bacitracin ointment containing, in each gram, 500 units of bacitracin in a suitable ointment base.
  2. (b)Bacitracin zinc ointment containing, in each gram, 500 units of bacitracin zinc in a suitable ointment base.
  3. (c)Chlortetracycline hydrochloride ointment containing, in each gram, 30 milligrams of chlortetracycline hydrochloride in a suitable ointment base.
  4. (d)Neomycin sulfate ointment containing, in each gram, 3.5 milligrams of neomycin in a suitable water soluble or oleaginous ointment base.
  5. (e)Neomycin sulfate cream containing, in each gram, 3.5 milligrams of neomycin in a suitable cream base.
  6. (f)Tetracycline hydrochloride ointment containing, in each gram, 30 milligrams of tetracycline hydrochloride in a suitable ointment base.